A different kind of biotech company
Helping restore a sense of freedom for patients with hereditary angioedema (HAE) and other rare diseases
We are BioCryst. A different kind of biotech company. A global company with over three decades of experience in drug discovery, development, and commercialization, guided by our passion for not settling for “ordinary” in our quest to develop novel medicines. We listen. We understand. We know that little things can make a big difference to patients.
Our commitment to delivering extraordinary first-in-class or best-in-class oral small-molecule and injectable protein therapeutics is what sets BioCryst apart—and what we strive to achieve. Our transparent and supportive culture transforms employees into owners, converts challenges into resilience, and empowers people to achieve beyond what they think is possible. Let’s connect >>
A global company with a community promise
At BioCryst, advancing novel therapeutics for patients is our purpose. With our global presence, the work we do helps patients take part in the everyday activities they enjoy, wherever they live. We focus on breaking new ground by blending pioneering technology and science with a more people-focused approach. We deliver medicines that have the potential to not just move the needle, but move mountains, for patients.
Patients we serve
Our commitment to improving the lives of patients starts with listening to and understanding the needs of patients and their loved ones. It’s about building trust and working collaboratively with advocacy organizations. It’s about getting the right treatments into the hands of patients who need them most. This is the reason we’re here.
OUR MEDICINES
Our focus is on breaking new ground in HAE and other rare diseases. We are dedicated to delivering oral small-molecule and injectable protein therapeutics to patients, working to bring meaningful innovation to underserved communities and improve the lives of people facing complex and often life-threatening conditions.
ABOUT US
Founded in 1986, BioCryst is one of the oldest independent global biotechnology companies in operation. Guided by a commitment to never settle for ordinary, we strive to deliver novel medicines and make “extraordinary” a reality for as many patients as possible.